Lexaria Bioscience Corp

Lexaria Bioscience Corp’s latest rating changes from various analysts

Anna Perez

Lexaria Bioscience Corp’s recent filing unveils that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.